Here are three key players from Nanologix. Once on board we have not heard a single bit of news of accomplishments. John is there every day so we can assume he is getting things done. As far as Wheeler goes no word. Is he putting money in? Dr manley, this bothers me the most! He stated "I will make a concerted effort to get the necessary trials started and finished at places such as Harvard, Johns Hopkins and other institutions." It has been 5 months not a word of trials starting!
What is the common denominator? Are these guys incompetent? You decide!!!!
Mark Wheeler, MD
Mark Wheeler MD is a board certified Internist who is a former member of the faculty at Dartmouth Hitchcock Medical Center. Following Dartmouth he spent eight years as an Emergency Medicine physician, while simultaneously expanding his interest and investments in novel medical technologies. He has authored a biotechnology newsletter and participated in multiple rounds of financings of Merrimack Pharmaceuticals(NASD: MACK), Ception Therapeutics, Hemosonics LLC, Lev Tech, Inc., and Therasome, Inc.
Dr Giles Manley
NanoLogix is honored to welcome Giles Manley, MD to the NanoLogix Science Advisory Board (SAB). Dr. Manley brings a wealth of medical, legal and business knowledge to the SAB.
Dr. Manley’s acceptance statement: “I am grateful for the invitation, and very excited about being part of NanoLogix by serving on their Science Advisory Board. What NanoLogix has accomplished over the last several years is truly amazing. There is no comparable system in the world that can deliver bacterial identification as cost effectively, quickly and accurately as their BNF and BNP product line… Through my career I have formed acquaintances with the Chiefs of Obstetrics at some of the top medical institutions in our country. I will make a concerted effort to get the necessary trials started and finished at places such as Harvard, Johns Hopkins and other institutions. I am hopeful that by the end of 2013 the standard for GBS screening will include our near-15 minute test at time of labor.”
John W. Tracy, Jr.
General Operations Manager
John Tracy brings to NanoLogix extensive technology and manufacturing management experience gained from over 30 years at IBM and EMC. Mr. Tracy has experienced and managed through 30% organizational growth rates at both companies. Additionally, he managed teams across six states consisting of 12 managers, 150 employees and 1,100 customers. Mr. Tracy is well-versed in the vertical integration of all aspects of the production environment, from customer relations and internal operations to service and sales strategies.
Mr. Tracy started his career in 1979, servicing mainframe computers as a field engineer for IBM where he was promoted to several key management positions, including Field Service Manager and Service Delivery Manager. As a service director for EMC’s Northeast Region, Mr. Tracy led an organization of 150 people, was responsible for $30 million per year in maintenance revenue and supported $160 million in annual sales revenue. At the EMC corporate headquarters, he improved operational efficiencies at a time where the organization was experiencing rapid and global expansion. His work resulted in saving hundreds of millions of dollars in costs, while simultaneously improving service delivery and quality of life for employees. Mr. Tracy personally rolled out this program in North America and the Asia Pacific region while assisting with a similar European effort. Mr. Tracy believes strongly in employee empowerment. He feels that the key to success and productivity is to provide a safe, positive and autonomous working environment where employees can learn and grow.
Market Data 
Markets 
AI
